Prosecution Insights
Last updated: October 04, 2026

National Cancer Center

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

12 pending office actions • 6 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 20 patents granted in the last 365 days

Analysis

National Cancer Center currently manages 11 pending office actions. These actions are located in the Medical Devices & Mechanical Engineering technology area. The portfolio involves 11 distinct examiners and 6 distinct art units. This distribution shows a level of technical and personnel diversity in the prosecution of the company's applications.

GARTLAND, SCOTT D is the busiest examiner, responsible for 1 pending office action. Because the number of distinct examiners is 11, which equals the number of pending actions, each examiner is reviewing only one case. This distribution requires the applicant to address 11 different examiner viewpoints across 6 different art units. The lack of concentration among examiners means that no single individual's tendencies will dominate the overall portfolio outcomes across the 6 art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

12
Total Pending OAs
8
Non-Final OAs
3
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (58%)
4
Medium (33%)
1
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (33%)
§103 only1 (8%)
§102 only3 (25%)
§112 only1 (8%)
Multi-statute (no §101)3 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
17% of docket
0
Information Tech
0% of docket
1
Communications
8% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
33% of docket
5
Business / Other
42% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

120 h
Manual time on pending OAs
24 h
Time saved (low, 20%)
42 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GARTLAND, SCOTT D 1 10.9% +12.2%
BARKER, DAYTON HYUN JIN 1 71.4% +40.0%
MCGRATH, ERIN E 1 60.1% +28.6%
ROZANSKI, GRACE NMN 1 60.5% +20.7%
MONAHAN, MEGAN ELIZABETH 1 58.0% +14.4%
EKRAMI, YASAMIN 1 41.6% +46.3%
LIPPERT, JOHN WILLIAM 1 58.2% +40.0%
VAZ, JANICE EZVI 1 77.0% +18.5%
FAIRCHILD, AARON BENJAMIN 1 79.6% +20.2%
WECKER, JENNIFER 1 71.0% +36.1%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18583630 ENDOSCOPE SYSTEM, METHOD FOR CONTROLLING ENDOSCOPE SYSTEM, AND RECORDING MEDIUM FAIRCHILD, AARON BENJAMIN 28d
19098192 METHOD AND APPARATUS FOR PROVIDING INFORMATION FOR PREDICTING MEDIASTINAL LYMPH NODE METASTASIS OF LUNG CANCER GARTLAND, SCOTT D —
18852432 BIOPSY NEEDLE MODULE USING MEDICAL IMAGING EQUIPMENT FOR REAL-TIME BIOPSY ROZANSKI, GRACE NMN —
18897470 ENDOSCOPE SYSTEM, PROCEDURE SUPPORT METHOD, AND RECORDING MEDIUM MONAHAN, MEGAN ELIZABETH —
18793301 NEAR-INFRARED FLUORESCENT DYE-LOADED POLYMER MICROSPHERES FOR LABELLING LESIONS, AND FORMULATION THEREOF LIPPERT, JOHN WILLIAM —
18637665 IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD, AND COMPUTER PROGRAM VAZ, JANICE EZVI —
18566404 BIOMARKER COMPOSITION CONTAINING ACYL CARNITINE METABOLITE FOR DIAGNOSIS OF ORAL CANCER WECKER, JENNIFER —

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18583630 ENDOSCOPE SYSTEM, METHOD FOR CONTROLLING ENDOSCOPE SYSTEM, AND RECORDING MEDIUM FAIRCHILD, AARON BENJAMIN 28d
19098192 METHOD AND APPARATUS FOR PROVIDING INFORMATION FOR PREDICTING MEDIASTINAL LYMPH NODE METASTASIS OF LUNG CANCER GARTLAND, SCOTT D —
19049859 ENDOSCOPE SYSTEM, CONTROL DEVICE, CONTROL METHOD, AND STORAGE MEDIUM BARKER, DAYTON HYUN JIN —
19037342 GRIPPING FORCEPS AND SUTURING METHOD MCGRATH, ERIN E —
18852432 BIOPSY NEEDLE MODULE USING MEDICAL IMAGING EQUIPMENT FOR REAL-TIME BIOPSY ROZANSKI, GRACE NMN —
18897470 ENDOSCOPE SYSTEM, PROCEDURE SUPPORT METHOD, AND RECORDING MEDIUM MONAHAN, MEGAN ELIZABETH —
18839816 HAIR LOSS PREVENTING DEVICE FOR ANTICANCER TREATMENT EKRAMI, YASAMIN —
18793301 NEAR-INFRARED FLUORESCENT DYE-LOADED POLYMER MICROSPHERES FOR LABELLING LESIONS, AND FORMULATION THEREOF LIPPERT, JOHN WILLIAM —

Top Art Units

Art UnitApps
3795 2
3685 1
3794 1
2667 1
1651 1
1644 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19098192 METHOD AND APPARATUS FOR PROVIDING INFORMATION FOR PREDICTING MEDIASTINAL LYMPH NODE METASTASIS OF LUNG CANCER GARTLAND, SCOTT D 3685 §101§112 Final Rejection — Pending Apr 02, 2025
19049859 ENDOSCOPE SYSTEM, CONTROL DEVICE, CONTROL METHOD, AND STORAGE MEDIUM BARKER, DAYTON HYUN JIN — §112 Non-Final OA — Pending Feb 10, 2025
19037342 GRIPPING FORCEPS AND SUTURING METHOD MCGRATH, ERIN E — §102 Non-Final OA — Pending Jan 27, 2025
18852432 BIOPSY NEEDLE MODULE USING MEDICAL IMAGING EQUIPMENT FOR REAL-TIME BIOPSY ROZANSKI, GRACE NMN — §103§112 Non-Final OA — Pending Sep 27, 2024
18897470 ENDOSCOPE SYSTEM, PROCEDURE SUPPORT METHOD, AND RECORDING MEDIUM MONAHAN, MEGAN ELIZABETH 3795 §102§112 Non-Final OA — Pending Sep 26, 2024
18839816 HAIR LOSS PREVENTING DEVICE FOR ANTICANCER TREATMENT EKRAMI, YASAMIN 3794 §103 Non-Final OA — Pending Aug 20, 2024
18793301 NEAR-INFRARED FLUORESCENT DYE-LOADED POLYMER MICROSPHERES FOR LABELLING LESIONS, AND FORMULATION THEREOF LIPPERT, JOHN WILLIAM — §103§112 Non-Final OA — Pending Aug 02, 2024
18637665 IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD, AND COMPUTER PROGRAM VAZ, JANICE EZVI 2667 §101§102§103§112 Non-Final OA — Pending Apr 17, 2024
18583630 ENDOSCOPE SYSTEM, METHOD FOR CONTROLLING ENDOSCOPE SYSTEM, AND RECORDING MEDIUM FAIRCHILD, AARON BENJAMIN 3795 §101§102§103§112 Final Rejection 28d Pending Feb 21, 2024
18566404 BIOMARKER COMPOSITION CONTAINING ACYL CARNITINE METABOLITE FOR DIAGNOSIS OF ORAL CANCER WECKER, JENNIFER — §101§103 Final Rejection — Pending Dec 01, 2023
18250913 APPLICATION OF PREVOTELLA STERCOREA STRAIN FOR CANCER PREVENTION OR TREATMENT ARMATO JR, DENNIS IGNATIUS 1651 §102 Non-Final OA 84d Pending Apr 27, 2023
17904926 METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING OR PREDICTING PROGNOSIS OF CANCER BY MEASURING EXPRESSION LEVEL OF TIM-3 IN CD11B+ CELLS BELYAVSKYI, MICHAIL A 1644 §102 Non-Final OA — Pending Aug 24, 2022

Managing National Cancer Center's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month